Convatec Group Plc (CNVVF)
Convatec Group Market Cap : 6.645B for March 18, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Silence Therapeutics Plc | 283.40M |
| Adaptimmune Therapeutics Plc | 4.771M |
| Biodexa Pharmaceuticals Plc | 0.5737M |
| Oxford Biomedica Plc | 982.08M |
| NuCana Plc | 7.242M |
Market Cap Related Metrics
| PE Ratio | 39.86 |
| PS Ratio | 2.859 |
| PEG Ratio | 1.161 |
| Price to Free Cash Flow | 24.46 |
| Price | 3.40 |
| Earnings Yield | 2.51% |
| PEGY Ratio | 1.098 |
| Operating PE Ratio | 17.05 |
| Normalized PE Ratio | 28.55 |